SCHEMBL7705104

SCHEMBL7705104

CC(=O)Oc1c(C)cc(OCC2CO2)c(C)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
GLA P06280 1/20 0.45
POLB P06746 1/20 0.43
HTT P42858 3/20 0.42
VDR P11473 1/20 0.40
TP53 P04637 4/20 0.37
TSHR P16473 3/20 0.37
HIF1A Q16665 2/20 0.37
CYP3A4 P08684 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 3/20 0.36
GAA P10253 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
PTPN1 P18031 2/20 0.35
HPGD P15428 2/20 0.34
LMNA P02545 2/20 0.34
PKM P14618 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7734885 0.86 ALDH1A1 (0.54) ALDH1A1GLAVDRTP53TSHR
SCHEMBL7705003 0.84 ALDH1A1 (0.49) ALDH1A1GLAPOLBHTTVDR
SCHEMBL7713504 0.82 ALDH1A1 (0.51) ALDH1A1GLAPOLBHTTVDR
SCHEMBL20679044 0.78 ALDH1A1 (0.56) ALDH1A1GLAPOLBVDRTP53
SCHEMBL8203102 0.77 ALDH1A1 (0.54) ALDH1A1GLAVDRTP53TSHR
SCHEMBL9015990 0.77 HTT (0.44) ALDH1A1POLBHTTTP53TSHR
SCHEMBL2910532 0.76 POLB (0.62) ALDH1A1GLAPOLBHTTTP53
SCHEMBL4947341 0.75 ALDH1A1 (0.47) ALDH1A1GLAVDRTP53TSHR
SCHEMBL13416124 0.75 ALDH1A1 (0.61) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL7096822 0.75 HTT (0.45) ALDH1A1POLBHTTTP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358515-B2 ANTIHYPERTENSIVE PHARMACEUTICAL COMPOSITION; TREATMENT OF GLAUCOMA SENJU PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
US-20010008893-A1 HYDROQUINONE DERIVATIVES SENJU PHARMACEUTICAL CO., LTD. (JP) 2001-07-19 US disclosed
EP-0972766-A1 HYDROQUINONE DERIVATIVES Senju Pharmaceutical Co., Ltd. (JP) 2000-01-19 EP disclosed
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008893-A1 HYDROQUINONE DERIVATIVES REN, AGTR1, AGTR2 ALDH1A1 128/4885GLA 3905/4885POLB 1474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.